External Advisory Board

Michael Kastan, MD, PhD  (Chair) – Duke

Executive Director, Duke Cancer Institute
Professor, Pharmacology and Cancer Biology

Stanton Gerson, MD – Case Western

Director, Case Comprehensive Cancer Center
Director, Seidman Cancer Center
Professor, Hematological Oncology

Jennifer Grandis, MD – UCSF

Director, Clinical and Translational Science Institute
Associate Vice Chancellor, Clinical & Translational Research
Professor, Otolaryngology – Head and Neck Surgery

Electra Paskett, PhD – Ohio State

Associate Director for Population Sciences
Division Chair, Cancer Prevention and Control
Professor, School of Public Health

 

Simon Powell, MD, PhD – Memorial Sloan Kettering

Chair and Professor, Department of Radiation Oncology

Timothy Rebbeck, PhD – Harvard/Dana Farber

Vincent L Gregory, Jr, Professor of Cancer Prevention
Director, Zhu Family Center for Global Cancer Prevention

 

Lynn Schuchter, MD - UPenn

Division Chief, Hematology-Oncology
Program Leader, Melanoma Program
Professor, Hematology-Oncology

Richard Jones, MD – Johns Hopkins

Director, Bone Marrow Transplantation
Co-Director, Hematologic Malignancies Program
Professor, Oncology and Medicine

 

Carl June, MD – UPenn

Director, Translational Research
Professor, Pathology and Laboratory Medicine

 

Mia Levy, MD, PhD – Rush

Director, Cancer Center, Rush University Medical Center
System Vice President for Cancer Services at Rush System for Health
Associate Professor, Internal Medicine

 

Marcy Waldinger, MHSA – Consultant

Consultant to NCI Designated Cancer Centers

 

Eileen White, PhD – Rutgers

Deputy Director
Chief Scientific Officer
Associate Director for Basic Research
Professor, Molecular Biology and Biochemistry

 

Eric Winer, MD – Dana Farber

Chief, Division of Breast Oncology, and of Women’s Cancers
Chief Clinical Strategy Officer
Leader, Breast Cancer Research Program
Professor, Medicine